QIAGEN Expands QIAcuity Digital PCR Portfolio Into Gene Expression, Cell And Gene Therapy And Automated Workflows To Drive Broader Adoption Across Life Sciences

Benzinga Newsdesk www.benzinga.com Positive 89.8%

Neg 0% Neu 0% Pos 89.8%

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas
Expanded Cell and Gene Therapy offerings and workflow automation capabilities strengthen the QIAcuity digital PCR ecosystem
New software capabilities support standardized analysis and reporting across digital PCR workflows

Comments

No comments yet. Be the first!